Although it may not be sufficient alone to guarantee protection from infection, a conserved CD4+ T cell immunity against common SARS-CoV-2 VOCs may be fundamental to reduce disease severity, as demonstrated by the importance of a rapid T cell response in preventing severe COVID-19 (27). The gene discussed is CD4; the disease is COVID-19.